Tag: Epicutaneous Immunotherapy (EPIT)

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Peanut Patch Receives FDA's Breakthrough Therapy Designation

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.